Selection of treatment for patients with carotid artery disease

Medication, carotid endarterectomy, or carotid artery stenting

Marc Bosiers, Patrick Peeters, Koen Deloose, Jürgen Verbist, Larry Richard Sprouse

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Patients presenting with atherosclerosis of the extracranial carotid arteries may be offered carotid endarterectomy (CEA), carotid artery stenting (CAS), or medical therapy to reduce their risk of stroke. In many cases, the choice between treatment modalities remains controversial. An algorithm based on patients' neurologic symptoms, comorbidities, limiting factors for CAS and CEA, and personal preferences was developed to determine the optimal treatment in each case. This algorithm was then employed to determine therapy in 308 consecutive patients presenting to a single institution during one calendar year. Ninety-five (30.8%) patients presented with an asymptomatic carotid stenosis of more than 80% and 213 (69.2%) with a symptomatic stenosis of more than 50%. According to our algorithm, 59 (62.1%) of the 95 asymptomatic patients received CAS, 20 (21.1%) received CEA, and 16 (16.8%) received medical therapy. All symptomatic patients underwent intervention; 153 (71.8%) were treated with CAS and 60 (28.2%) with CEA. Combined 30-day stroke and death rates after CAS were 1.7% in asymptomatic patients and 2.6% in symptomatic patients. After CEA, these rates were 0% and 3.3%, respectively. Careful selection of treatment modality according to predetermined criteria can result in improved outcomes.

Original languageEnglish (US)
Pages (from-to)92-97
Number of pages6
JournalVascular
Volume13
Issue number2
DOIs
StatePublished - Jan 1 2005
Externally publishedYes

Fingerprint

Carotid Artery Diseases
Carotid Endarterectomy
Carotid Arteries
Patient Selection
Therapeutics
Stroke
Carotid Stenosis
Neurologic Manifestations
Comorbidity
Atherosclerosis
Pathologic Constriction
Mortality

All Science Journal Classification (ASJC) codes

  • Surgery
  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Selection of treatment for patients with carotid artery disease : Medication, carotid endarterectomy, or carotid artery stenting. / Bosiers, Marc; Peeters, Patrick; Deloose, Koen; Verbist, Jürgen; Sprouse, Larry Richard.

In: Vascular, Vol. 13, No. 2, 01.01.2005, p. 92-97.

Research output: Contribution to journalArticle

Bosiers, Marc ; Peeters, Patrick ; Deloose, Koen ; Verbist, Jürgen ; Sprouse, Larry Richard. / Selection of treatment for patients with carotid artery disease : Medication, carotid endarterectomy, or carotid artery stenting. In: Vascular. 2005 ; Vol. 13, No. 2. pp. 92-97.
@article{1dbe6fc9bc374aae995af4f90bb4637e,
title = "Selection of treatment for patients with carotid artery disease: Medication, carotid endarterectomy, or carotid artery stenting",
abstract = "Patients presenting with atherosclerosis of the extracranial carotid arteries may be offered carotid endarterectomy (CEA), carotid artery stenting (CAS), or medical therapy to reduce their risk of stroke. In many cases, the choice between treatment modalities remains controversial. An algorithm based on patients' neurologic symptoms, comorbidities, limiting factors for CAS and CEA, and personal preferences was developed to determine the optimal treatment in each case. This algorithm was then employed to determine therapy in 308 consecutive patients presenting to a single institution during one calendar year. Ninety-five (30.8{\%}) patients presented with an asymptomatic carotid stenosis of more than 80{\%} and 213 (69.2{\%}) with a symptomatic stenosis of more than 50{\%}. According to our algorithm, 59 (62.1{\%}) of the 95 asymptomatic patients received CAS, 20 (21.1{\%}) received CEA, and 16 (16.8{\%}) received medical therapy. All symptomatic patients underwent intervention; 153 (71.8{\%}) were treated with CAS and 60 (28.2{\%}) with CEA. Combined 30-day stroke and death rates after CAS were 1.7{\%} in asymptomatic patients and 2.6{\%} in symptomatic patients. After CEA, these rates were 0{\%} and 3.3{\%}, respectively. Careful selection of treatment modality according to predetermined criteria can result in improved outcomes.",
author = "Marc Bosiers and Patrick Peeters and Koen Deloose and J{\"u}rgen Verbist and Sprouse, {Larry Richard}",
year = "2005",
month = "1",
day = "1",
doi = "10.1258/rsmvasc.13.2.92",
language = "English (US)",
volume = "13",
pages = "92--97",
journal = "Vascular",
issn = "1708-5381",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Selection of treatment for patients with carotid artery disease

T2 - Medication, carotid endarterectomy, or carotid artery stenting

AU - Bosiers, Marc

AU - Peeters, Patrick

AU - Deloose, Koen

AU - Verbist, Jürgen

AU - Sprouse, Larry Richard

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Patients presenting with atherosclerosis of the extracranial carotid arteries may be offered carotid endarterectomy (CEA), carotid artery stenting (CAS), or medical therapy to reduce their risk of stroke. In many cases, the choice between treatment modalities remains controversial. An algorithm based on patients' neurologic symptoms, comorbidities, limiting factors for CAS and CEA, and personal preferences was developed to determine the optimal treatment in each case. This algorithm was then employed to determine therapy in 308 consecutive patients presenting to a single institution during one calendar year. Ninety-five (30.8%) patients presented with an asymptomatic carotid stenosis of more than 80% and 213 (69.2%) with a symptomatic stenosis of more than 50%. According to our algorithm, 59 (62.1%) of the 95 asymptomatic patients received CAS, 20 (21.1%) received CEA, and 16 (16.8%) received medical therapy. All symptomatic patients underwent intervention; 153 (71.8%) were treated with CAS and 60 (28.2%) with CEA. Combined 30-day stroke and death rates after CAS were 1.7% in asymptomatic patients and 2.6% in symptomatic patients. After CEA, these rates were 0% and 3.3%, respectively. Careful selection of treatment modality according to predetermined criteria can result in improved outcomes.

AB - Patients presenting with atherosclerosis of the extracranial carotid arteries may be offered carotid endarterectomy (CEA), carotid artery stenting (CAS), or medical therapy to reduce their risk of stroke. In many cases, the choice between treatment modalities remains controversial. An algorithm based on patients' neurologic symptoms, comorbidities, limiting factors for CAS and CEA, and personal preferences was developed to determine the optimal treatment in each case. This algorithm was then employed to determine therapy in 308 consecutive patients presenting to a single institution during one calendar year. Ninety-five (30.8%) patients presented with an asymptomatic carotid stenosis of more than 80% and 213 (69.2%) with a symptomatic stenosis of more than 50%. According to our algorithm, 59 (62.1%) of the 95 asymptomatic patients received CAS, 20 (21.1%) received CEA, and 16 (16.8%) received medical therapy. All symptomatic patients underwent intervention; 153 (71.8%) were treated with CAS and 60 (28.2%) with CEA. Combined 30-day stroke and death rates after CAS were 1.7% in asymptomatic patients and 2.6% in symptomatic patients. After CEA, these rates were 0% and 3.3%, respectively. Careful selection of treatment modality according to predetermined criteria can result in improved outcomes.

UR - http://www.scopus.com/inward/record.url?scp=17444380043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17444380043&partnerID=8YFLogxK

U2 - 10.1258/rsmvasc.13.2.92

DO - 10.1258/rsmvasc.13.2.92

M3 - Article

VL - 13

SP - 92

EP - 97

JO - Vascular

JF - Vascular

SN - 1708-5381

IS - 2

ER -